AstraZeneca to Create Distinct Vaccine and Antibodies Business

AstraZeneca is setting up a new business unit dedicated to overseeing its vaccines and antibody therapies as it looks to rebound from pandemic-era disappointments related to its COVID-19 jab co-developed with Oxford University.
Source: Drug Industry Daily